The Cancer Epidemiology Descriptive Cohort Database: A Tool to Support Population-Based Interdisciplinary Research
暂无分享,去创建一个
Muin J. Khoury | John P.A. Ioannidis | Gabriel Y. Lai | J. Ioannidis | M. Khoury | D. Seminara | Amy Miller | A. Kennedy | Daniela Seminara | Michelle Brotzman | Scott D. Rogers | G. Lai | Amy E. Kennedy | Amy Miller | Crystal Lane | Chinonye Harvey | Joanne W. Elena | M. Brotzman | J. Elena | C. Lane | Chinonye E. Harvey
[1] Eric Boerwinkle,et al. Strategic transformation of population studies: recommendations of the working group on epidemiology and population sciences from the National Heart, Lung, and Blood Advisory Council and Board of External Experts. , 2015, American journal of epidemiology.
[2] W. Riley,et al. Precision Public Health for the Era of Precision Medicine. , 2016, American journal of preventive medicine.
[3] J. Manson,et al. Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium. , 2012, Blood.
[4] John D Potter,et al. Toward Rigorous Data Harmonization in Cancer Epidemiology Research: One Approach. , 2015, American journal of epidemiology.
[5] D. Altshuler,et al. Genetic Variation in the HSD17B1 Gene and Risk of Prostate Cancer , 2005, PLoS genetics.
[6] J Jack Lee,et al. Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] M. Lawler,et al. Personalised and Precision Medicine in Cancer Clinical Trials: Panacea for Progress or Pandora's Box? , 2015, Public Health Genomics.
[8] Eduardo L. Franco,et al. Making Prospective Registration of Observational Research a Reality , 2014, Science Translational Medicine.
[9] Eric Boerwinkle,et al. Translational Genomics is Not a Spectator Sport: A Call to Action , 2012, Genetic epidemiology.
[10] J. Silverman. To register or not to register , 2015, Lab Animal.
[11] J. Ioannidis,et al. Transforming Epidemiology for 21st Century Medicine and Public Health , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[12] Geoffrey S. Tobias,et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer , 2009, Nature Genetics.
[13] Graham A. Colditz,et al. Merging and emerging cohorts: Not worth the wait , 2007, Nature.
[14] Geoffrey S. Tobias,et al. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. , 2009, American journal of epidemiology.
[15] A. Wägner,et al. Fertility is reduced in women and in men with type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium (T1DGC) , 2014, Diabetologia.
[16] M. Pike,et al. A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3) , 2006, Breast Cancer Research.
[17] W. Willett,et al. Multiple loci identified in a genome-wide association study of prostate cancer , 2008, Nature Genetics.
[18] M. Pike,et al. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. , 2014, Journal of the National Cancer Institute.
[19] Adam S. Kibel,et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007 .
[20] M. Khoury,et al. A public health perspective on a national precision medicine cohort: balancing long-term knowledge generation with early health benefit. , 2015, JAMA.
[21] M. Bracken. Preregistration of epidemiology protocols: a commentary in support. , 2011, Epidemiology.
[22] J. Ioannidis,et al. Nested Randomized Trials in Large Cohorts and Biobanks: Studying the Health Effects of Lifestyle Factors , 2008, Epidemiology.
[23] Michael S. Lauer,et al. Time for a creative transformation of epidemiology in the United States. , 2012, JAMA.
[24] J. Potter. Epidemiology informing clinical practice: from bills of mortality to population laboratories , 2005, Nature Clinical Practice Oncology.
[25] J. Ioannidis,et al. Registering diagnostic and prognostic trials of tests: is it the right thing to do? , 2014, Clinical chemistry.
[26] R. Hayes,et al. Circulating 25-Hydroxyvitamin D and the Risk of Rarer Cancers: Design and Methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers , 2010, American journal of epidemiology.